EUVIMEDEUVIMED entdecken
Crossref

Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?

Alferes, Daniela, Inês Coelho, Hugo Ferreira, Teresa Chuva, Paiva, Ana, Sergio Pereira Chacim, Mariz, José Mário, Maximino Costa, José

Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · 04.01.2024

DOI: 10.71749/pkj.20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT), erschienen am 04.01.2024. Verfasst von Alferes und 11 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chimeric antigen receptor (CAR) T‑cell therapy is an effective new treatment for hematologic malignancies. In this study, we aimed to characterize the acute kidney injury (AKI) and electrolyte disorders among adults with refractory and relapsed haematological malignancies treated with CAR‑T therapy and explore clinical outcomes.

Methods

A retrospective, observational study was performed. Adult patients who received anti‑CD19 CAR ‑T therapy between January 2019 and July 2022 were screened for inclusion.

Results

Among 41 patients receiving CAR T‑cell therapy, cytokine release syndrome and neurotoxicity rates occurred in 65.9% and 19.5%, respectively. AKI occurred in 6 patients (14.6%): 4 had stage 1 AKI and 2 developed stage 2 AKI, all related to decreased kidney perfusion. Electrolyte abnormalities occurred in 65.9% and most of them were clinically mild.

Conclusion

In this study, the incidence of AKI was low, with a complete resolution in most cases by the end of follow‑up. Electrolyte abnormalities were common among recipients of CAR ‑T, although of low severity.

Schlagwörter

CAR T-cell therapyacute kidney injurynephrotoxicityCD19 CAR-Thematologic malignanciescytokine release syndromeneurotoxicityelectrolyte imbalancerenal perfusion

Zitieren

APA

Alferes, Daniela, Coelho, I., Ferreira, H., Chuva, T., Paiva, Ana, Chacim, S. P., Mariz, Mário, J., Costa, M., & José (2024). Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). https://doi.org/10.71749/pkj.20

Vancouver

Alferes, Daniela, Coelho I, Ferreira H, Chuva T, Paiva, et al. Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 2024. doi:10.71749/pkj.20

BibTeX
@article{Alferes2024,
  author = {Alferes and Daniela and Coelho, Inês and Ferreira, Hugo and Chuva, Teresa and Paiva and Ana and Chacim, Sergio Pereira and Mariz and Mário, José and Costa, Maximino and José},
  title = {Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?},
  journal = {Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)},
  year = {2024},
  doi = {10.71749/pkj.20}
}
Kostenlos starten →